Abstracts

Abstract notifications have been sent via e-mail. Please check your inbox.

If you submitted an abstract, but do not see a notification, please check your spam filter.
If you do not have a notification in either your inbox or spam filter, please contact info@ispdhome.org.


Conference sessions will be held Monday–Wednesday, 9–11 July 2018. See the Program.

Abstracts were submitted in the categories listed at the bottom of this page. Presenters are required to register for the conference, at least for the day of his/her presentation. Presenters should make every effort to attend; if that becomes impossible, please contact us at info@ispdhome.org to arrange a presenter substitution.
 

Abstract Types

Oral Presentation

  • Podium presentation in a concurrent session*
  • Wide-screen slide format (16:9)
  • Peer reviewers will select the top oral abstracts for presentation in a special plenary session.*
  • Abstracts by early career investigators will be considered for the Joe Leigh Simpson Award.
Information for Oral Presenters

Poster Presentation

  • Attended poster session on either Monday, 9 July 2018, or Tuesday, 10 July 2018*
  • Poster authors with the highest peer review scores have been invited to give a brief oral presentation during a conference session on Monday, 9 July 2018. Each presenter will have 2 minutes to speak and 2 minutes for Q&A. These authors are also expected to present the paper poster during the scheduled poster session.
Information for Poster Presenters

* Presenters must register for the conference, at least for the day of their assigned session. Presenters who are unable to attend on their assigned day may have a co-author present in their place and must contact ISPD Headquarters to make this substitution.
 



The following categories were available for submission.
  • Cytogenetics and Molecular Genetics
  • Epigenetics and development
  • Fetal and placental development and pathology
  • Fetal imaging: Ultrasound and Magnetic Resonance Imaging
  • Fetal medical and surgical therapy
  • Global issues in prenatal diagnosis and screening
  • Maternal serum/NT screening for aneuploidy
  • Noninvasive prenatal diagnosis and screening
  • Pre-implantation genetic diagnosis and screening
  • Prenatal diagnosis of single gene disorders / inborn errors of metabolism
  • Prenatal diagnostic procedures
  • Prenatal genetic counseling
  • Prenatal prediction of adverse pregnancy outcomes (e.g pre-eclampisa / preterm labour / growth restriction and stillbirth)
  • Psychosocial, legal and ethical issues in prenatal screening and diagnosis
  • Reproductive genomics, metabolomics and proteomics
  • Screening for single gene disorders
  • Teratogens and Fetal infection
  • Twins
  • Other
Published abstracts from previous years are available through the Downloads page.